Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec H | Hong Kong | Salute | Ricerca medica e biotecnologica | 144,45 Mrd HKD | 16x | -1,96 | 49,85 HKD | 20,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,8% Rialzo | Fai l’upgrade a Pro+ | |
Tigermed | Hong Kong | Salute | Ricerca medica e biotecnologica | 57,76 Mrd HKD | 44,7x | -0,73 | 34,50 HKD | 11,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,1% Rialzo | Fai l’upgrade a Pro+ | |
WuXi Biologics | Hong Kong | Salute | Ricerca medica e biotecnologica | 56,96 Mrd HKD | 19,2x | -0,51 | 16,10 HKD | 16,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 28,3% Rialzo | Fai l’upgrade a Pro+ | |
Akeso | Hong Kong | Salute | Ricerca medica e biotecnologica | 55,37 Mrd HKD | -53,5x | 0,51 | 68,25 HKD | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,2% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaron Beijing Co Ltd | Hong Kong | Salute | Ricerca medica e biotecnologica | 50,41 Mrd HKD | 22,5x | 0,82 | 12,90 HKD | 14,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,3% Rialzo | Fai l’upgrade a Pro+ | |
Sichuan Kelun Biotech | Hong Kong | Salute | Ricerca medica e biotecnologica | 37,73 Mrd HKD | -183,6x | -2,81 | 171 HKD | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,7% Rialzo | Fai l’upgrade a Pro+ | |
Genscript Biotech Corp | Hong Kong | Salute | Ricerca medica e biotecnologica | 28,05 Mrd HKD | -19,9x | -4,09 | 13,12 HKD | 16,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Beigene | Hong Kong | Salute | Ricerca medica e biotecnologica | 14,25 Mrd HKD | -3,4x | -0,59 | 133,90 HKD | 4,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,3% Rialzo | Fai l’upgrade a Pro+ | |
Joinn Laboratories China Co | Hong Kong | Salute | Ricerca medica e biotecnologica | 13,38 Mrd HKD | 88,7x | -0,82 | 8,93 HKD | 17,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,6% Rialzo | Fai l’upgrade a Pro+ | |
Lepu Biopharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 12,78 Mrd HKD | -49,2x | -0,77 | 3,42 HKD | 8,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lepu Biopharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 12,78 Mrd HKD | -49,2x | -0,77 | 3,42 HKD | 8,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Remegen | Hong Kong | Salute | Ricerca medica e biotecnologica | 12,68 Mrd HKD | -3,3x | 0,19 | 15,82 HKD | 19,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ascentage Pharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 11,98 Mrd HKD | -24,7x | -0,49 | 40,90 HKD | 5,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1% Rialzo | Fai l’upgrade a Pro+ | |
Innocare | Hong Kong | Salute | Ricerca medica e biotecnologica | 11,48 Mrd HKD | -16,1x | -0,48 | 6,05 HKD | 8,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Keymed Biosciences | Hong Kong | Salute | Ricerca medica e biotecnologica | 10,21 Mrd HKD | -11,6x | 0,07 | 40,45 HKD | 9,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Qyuns Therapeutics | Hong Kong | Salute | Ricerca medica e biotecnologica | 5,37 Mrd HKD | -11,1x | 28,50 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Alphamab | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,72 Mrd HKD | -10x | -27,68 | 3,07 HKD | 8,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22,1% Rialzo | Fai l’upgrade a Pro+ | |
Biocytogen Pharmaceuticals Beijing | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,50 Mrd HKD | -9,2x | -0,17 | 6,65 HKD | 6,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Abbisko Cayman | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,13 Mrd HKD | -139,2x | -1,13 | 3,40 HKD | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CARsgen Therapeutics Holdings | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,10 Mrd HKD | -2x | -0,09 | 4,15 HKD | 13,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CStone | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,91 Mrd HKD | -13,2x | -0,07 | 1,74 HKD | 16% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
ImmuneOnco Biopharmaceuticals | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,87 Mrd HKD | -4,2x | -7,03 | 5,97 HKD | 19,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Tot Biopharm Intl | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,57 Mrd HKD | 146,3x | 1,32 | 1,97 HKD | -3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Frontage Holdings | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,48 Mrd HKD | 25,8x | -0,41 | 0,78 HKD | 6,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Jacobio Pharmaceuticals Group | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,39 Mrd HKD | -3,3x | -0,25 | 1,86 HKD | 5,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mabpharm | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,36 Mrd HKD | -6,5x | 0,83 | 0,33 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hua Medicine | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,28 Mrd HKD | -4,4x | 0,1 | 1,31 HKD | 7,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Immunotech | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,26 Mrd HKD | -4,3x | 1,19 | 2,50 HKD | 2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Wuhan YZY Biopharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,15 Mrd HKD | -5,8x | -0,79 | 5,92 HKD | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genor Biopharma Holdings | Hong Kong | Salute | Ricerca medica e biotecnologica | 851,72 Mln HKD | -1,3x | -0,12 | 1,65 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |